TERMINATION AND WAIVER AGREEMENTTermination and Waiver Agreement • September 24th, 2009 • Habersham Bancorp • State commercial banks • Georgia
Contract Type FiledSeptember 24th, 2009 Company Industry JurisdictionTHIS TERMINATION AND WAIVER AGREEMENT (this “Termination Agreement”) is made and entered into as of this 19th day of September, 2009 (the “Effective Date”) by and between HABERSHAM BANK (the “Bank”), and JAMES A. STAPLETON, JR., a resident of the State of Georgia (the “Director”).
November 12, 2015 By Electronic Mail and Facsimile Neurosciences Research Venures, Inc.Termination and Waiver Agreement • March 30th, 2021 • Synaptogenix, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 30th, 2021 Company Industry
EXHIBIT 99.1 TERMINATION AND WAIVER AGREEMENT This TERMINATION AND WAIVER AGREEMENT (this "Agreement") is made and entered into as of April 29, 2008 by and among MACC PRIVATE EQUITIES INC., a Delaware corporation ("MACC"), MORAMERICA CAPITAL...Termination and Waiver Agreement • May 1st, 2008 • Macc Private Equities Inc • Delaware
Contract Type FiledMay 1st, 2008 Company Jurisdiction
TERMINATION AND WAIVER AGREEMENTTermination and Waiver Agreement • September 14th, 2009 • Habersham Bancorp • State commercial banks • Georgia
Contract Type FiledSeptember 14th, 2009 Company Industry JurisdictionTHIS TERMINATION AND WAIVER AGREEMENT (this “Termination Agreement”) is made and entered into as of this 8th day of September, 2009 (the “Effective Date”) by and between HABERSHAM BANCORP (the “Company”), the parent company of HABERSHAM BANK (the “Bank”) and BONNIE BOWLING, a resident of the State of Georgia (the “Executive”).
INSIGNIA SOLUTIONS PLC INSIGNIA SOLUTIONS INTERNATIONAL LIMITED INSIGNIA SOLUTIONS, INC INSIGNIA SOLUTIONS SARL ESMERTEC AG TERMINATION AND WAIVER AGREEMENT Macfarlanes London EC4A 1BD WGD/573886Termination and Waiver Agreement • August 13th, 2004 • Insignia Solutions PLC • Services-prepackaged software
Contract Type FiledAugust 13th, 2004 Company IndustryA The parties are parties to an Asset Purchase Agreement dated 4 March 2003 (as amended, varied and supplemented) (the Main Agreement) pursuant to which the Insignia Parties have sold and Esmertec has purchased the Business, Assets and Deferred Assets (including intellectual property rights) as therein defined, as the parties hereby acknowledge.
TERMINATION AND WAIVER AGREEMENTTermination and Waiver Agreement • September 14th, 2009 • Habersham Bancorp • State commercial banks • Georgia
Contract Type FiledSeptember 14th, 2009 Company Industry JurisdictionTHIS TERMINATION AND WAIVER AGREEMENT (this “Termination Agreement”) is made and entered into as of this 8th day of September, 2009 (the “Effective Date”) by and between HABERSHAM BANK, a Georgia state bank (the “Bank”), and EDWARD D. ARIAIL, a resident of the State of Georgia (the “Executive”).
TERMINATION AND WAIVER AGREEMENTTermination and Waiver Agreement • August 7th, 2015 • Enstar Group LTD • Fire, marine & casualty insurance • New York
Contract Type FiledAugust 7th, 2015 Company Industry JurisdictionThis TERMINATION AND WAIVER AGREEMENT (this “Agreement”) is entered into as of June 3, 2015, by and among First Reserve Fund XII, L.P., a Cayman Islands limited partnership (“FRF”), FR XII-A Parallel Vehicle, L.P., a Cayman Islands limited partnership (“FRA”), FR XI Offshore AIV, L.P., a Cayman Islands limited partnership (“FR AIV”), FR Torus Co-Investment, L.P., a Cayman Islands limited partnership (“FRT” and together with FRF, FRA and FR AIV, the “Waiving Parties” and each a “Waiving Party”) and Enstar Group Limited, a Bermuda company (“Enstar”). Capitalized terms used herein without definitions shall have the respective meanings given to such terms in the Purchase Agreement (as defined below).
TERMINATION AND WAIVER AGREEMENTTermination and Waiver Agreement • November 5th, 2014 • Kythera Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 5th, 2014 Company Industry JurisdictionThis Termination and Waiver Agreement (this “Agreement”) is dated as of November 5, 2014, by and among KYTHERA Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), KYTHERA Holdings Ltd., a company incorporated under the laws of Bermuda (“KHL”) (solely for purposes of Article II hereof), and Bayer Consumer Care AG, a company organized under the laws of Switzerland (“Bayer”).